VASCULAR SMOOTH MUSCLE CELLS (VSMCs) in the media layer of vessel wall determine the diameter of blood vessels and thus control the peripheral resistances and the blood pressure. However, it is now recognized that the VSMC is not only a contractile cell but also exhibits other important functions such as secretion, migration, proliferation, and apoptosis. Thus the VSMC appears today as a fascinating cell with remarkable phenotypic plasticity that contributes to its roles in health and disease. An increase in the intracellular Ca 2ϩ ions concentration ([Ca 2ϩ ] i ) is a key event in a variety of phenomena accompanying the evolution of a smooth muscle cell. The [Ca 2ϩ ] i value is the ultimate result of the intracellular Ca 2ϩ homeostasis, which is a fine balance among the entry, exit, and storage of Ca 2ϩ ions (3) . A variety of molecular entities contributing to Ca 2ϩ homeostasis has already been characterized such as Ca 2ϩ channels, Ca 2ϩ pumps and transporters, and calciproteins, all of them constituting the calciosome. In VSMCs and non-VSMCs, stored Ca 2ϩ ions in the sarco(endo) plasmic reticulum (S/ER) have been recognized for a long time as playing a crucial role in contractile responses to agonists (4, 5, 10, 14, 16) . Ca 2ϩ content of S/ER is determined by Ca 2ϩ uptake (influx) through S/ER Ca 2ϩ -ATPase pump (SERCA) and Ca 2ϩ efflux through Ca 2ϩ permeable channels of the endoplasmic reticulum (ER) membrane (2, 3) . Following agonist stimulation, two main types of Ca 2ϩ channels obviously participate in the Ca 2ϩ release from S/ER: the inositol 1,4,5-trisphosphate receptor/channel and the ryanodine receptor/ channel (2, 3a, 13, 17) . However, it is admitted that, in the absence of any stimulation, the S/ER membrane is permeable to Ca 2ϩ and a constitutive passive leak of Ca 2ϩ ions from the S/ER lumen to cytosol occurs leading to the progressive depletion of S/ER, which, under physiological conditions, is compensated by the SERCA activity. This phenomenon is supported in VSMCs by the observations that 1) agonistinduced [Ca 2ϩ ] i increases and contractions progressively disappeared with the duration of tissue incubation in Ca 2ϩ -free medium and 2) blockade of SERCA with specific inhibitors (thapsigargin and cyclopiazionic acid) induced a transient increase in [Ca 2ϩ ] i and subsequent contraction (8, 28) . Although it is becoming evident that the Ca 2ϩ leak from S/ER is an important component of the intracellular Ca 2ϩ homeostasis, the alteration of which could be implicated in some pathophysiological processes such as prostate cancer (25) , the molecular identity of such leak in the calciosome is not yet clearly identified. Whereas different proteins of the S/ER membrane such as pannexin-1, presenilin-1, and the translocon have been recently suggested to be responsible for the constitutive Ca 2ϩ leak in prostate cancer cell line, salivary gland cells, and nervous cells (6, 18, 19, (22) (23) (24) , very little information regarding this issue is available for VSMCs. In this respect, Amer et al. (1) have conducted an original work investigating the presence and the role of the translocon in proliferative VSMCs from the human saphenous vein, a vessel that is currently used for coronary artery bypass graft, which is prone to failure because of neointimal hyperplasia.
The translocon is a multimeric protein complex involved in the synthesis and translocation of nascent polypeptides into the ER. In eukaryotic cells, the translocation channel is comprised, at least in part, of multiple copies of the core Sec61␣␤␥ heterotrimer and several associated components such as translocation-associated membrane protein, oligosaccharyltransferase, signal peptidase complex, and BiP (26) . It has long been suggested that the cytosolic side of the translocon is blocked by the ribosome during translocation, whereas the protein BiP blocks the luminal side (11), thus preserving the permeability barrier across the ER. However, in non-smooth muscle cells, electrophysiological and fluorescence studies have demonstrated that the translocon is a protein-conducting channel that can also provide a leak pathway for ions and small molecules, especially Ca 2ϩ ions (12, 21, 23) . Moreover, since the depletion of the S/ER Ca 2ϩ content is known to induce subsequent Ca 2ϩ entry through specific store-operated channel, it was tempting to test the hypothesis that the translocon activity is implicated in store-operated Ca 2ϩ entry (also called capacitative Ca 2ϩ entry) (20) . Indeed, in salivary gland cells and tumourigenic prostatic cell lines, evidence has been brought about that Ca 2ϩ leak via the translocon activates store-operated channel (6, 19) , thus strengthening, in those cells, the central role of the translocon in the intracellular Ca 2ϩ homeostasis. Amer et al. (1) addressed the role of the translocon in cultured VSMCs using various polypeptide synthesis inhibitors: puromycin, which opens the translocon by mimicking aminoacyl tRNA releasing nascent protein polypeptide chain and the antibiotic anisomycin and antiprotozoal agent emetine, which close the translocon by inhibiting the peptidyl transferase. In a very elegant series of experiments, the authors show that although the translocon is present in ER membrane of proliferating VSMCs and has the capacity to make a Ca 2ϩ release channel as revealed by the puromycin-induced [Ca 2ϩ ] i increase, it is implicated neither in the constitutive Ca 2ϩ leak nor in the [Ca 2ϩ ] i responses induced by agonists such as ATP and endothelin-1. Indeed, [Ca 2ϩ ] i responses induced by thapsigargin, ATP, and endothelin-1 were not altered by the abovementioned protein synthesis inhibitors (anisomycin and emetine). Therefore, although Ca 2ϩ leak via the translocon remains a possibility in venous VSMCs, the translocon is normally closed and does not appear as the physiological passive Ca 2ϩ leak pathway. These results differ from previous reports in other cell types such as prostate cancer cell line and salivary gland cells (6, 19) and can appear contradictory since venous VSMCs were proliferating and actively synthesizing new proteins. In another way, the present study suggests a potential pharmacological interest of puromycin in vascular diseases since, by releasing Ca 2ϩ in VSMCs, it could facilitate VSMC apoptosis and therefore could contribute to stabilizing atherosclerotic plaques.
The general theory states that the translocon is closed and impermeable to small molecules when it is not translocating a protein. However, a recent work by Wonderlin (27) in native ER membranes from CHO-K1 cells shows that the translocon can be constitutively open at physiological temperature. This translation-independent constitutive opening of translocon provides new insight into the role of the translocon in the transport of small molecules across the ER membrane and is consistent with the view that the Ca 2ϩ content of the S/ER is mainly due to both the activity of SERCA and a constitutive leak pathway. This very interesting study also prompts an investigation into the role of the translocon in nonproliferative VSMCs. Moreover, this first investigation of the role of the translocon in the vascular system performed by Amer et al. (1) raises the following additional questions: 1) is the VSMC translocon molecular identity the same as in other eukaryotic cells? (no structural data are available at present); 2) are the translocon properties similar in arterial VSMC, owing that there are several differences between venous and arterial smooth muscle cells; 3) is the translocon the Ca 2ϩ leak pathway in other cardiorespiratory diseases such as pulmonary artery hypertension where VSMCs exhibit an altered [Ca 2ϩ ] i and a proliferative phenotype (9, 15) ?; 4) is another putative channel, different from the translocon, 1,4,5-trisphosphate receptor/channel and the ryanodine receptor/channel, the Ca 2ϩ leak pathway from S/ER membrane such as recently proposed in rat liver microsomes (7) . Obviously, further investigations will be required to elucidate the fascinating role of the translocon in vascular biology and pathophysiology.
